News

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...
Kennedy junior, America’s health secretary, recommended that thimerosal (also spelt thiomersal), an ingredient used in some ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
A CDC advisory has recommended to ban the use of thimerosal in flu shots despite no evidence that it causes any harm.